标题
Biologic fatigue in psoriasis
作者
关键词
-
出版物
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 25, Issue 1, Pages 78-82
出版商
Informa UK Limited
发表日期
2013-07-23
DOI
10.3109/09546634.2013.826341
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recommendations for the Long-Term Treatment of Psoriasis with Infliximab: A Dermatology Expert Group Consensus
- (2014) Kristian Reich et al. DERMATOLOGY
- Dose-creep of Infliximab During Psoriasis Treatment: An Observational Study
- (2013) C Mehren et al. ACTA DERMATO-VENEREOLOGICA
- Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)
- (2013) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Infliximab for the treatment of psoriasis in the U.K.: 9 years’ experience of infusion reactions at a single centre
- (2012) J.S. Wee et al. BRITISH JOURNAL OF DERMATOLOGY
- A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis
- (2012) A.B. Gottlieb et al. BRITISH JOURNAL OF DERMATOLOGY
- Plasma trough levels of adalimumab and infliximab in terms of clinical efficacy during the treatment of psoriasis
- (2012) Hidetoshi Takahashi et al. JOURNAL OF DERMATOLOGY
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
- (2011) R. Gniadecki et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)
- (2011) J. Barker et al. BRITISH JOURNAL OF DERMATOLOGY
- Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment: Table 1
- (2011) N Vande Casteele et al. GUT
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL
- (2011) Kenneth Gordon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Extent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque Psoriasis
- (2010) Lidian L. A. Lecluse et al. ARCHIVES OF DERMATOLOGY
- Dealing with immunogenicity of biologicals: assessment and clinical relevance
- (2010) Gerrit J Wolbink et al. CURRENT OPINION IN RHEUMATOLOGY
- The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review
- (2010) Charlotte Krieckaert et al. ARTHRITIS RESEARCH & THERAPY
- The Combination of Etanercept and Methotrexate Increases the Effectiveness of Treatment in Active Psoriasis Despite Inadequate Effect of Methotrexate Therapy
- (2008) C Zachariae et al. ACTA DERMATO-VENEREOLOGICA
- Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis
- (2008) S M van der Kooij et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
- (2008) M K de Vries et al. ANNALS OF THE RHEUMATIC DISEASES
- Etanercept combined with methotrexate for high-need psoriasis
- (2008) R.J.B. Driessen et al. BRITISH JOURNAL OF DERMATOLOGY
- Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate
- (2008) R. B. Warren et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2008) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort
- (2008) M Dalaker et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More